Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Нервные болезни
2020 / N 4

Ранняя диагностика вегетативной невропатии в амбулаторной практике
О.Е. Зиновьева, Л.Т. Ахмеджанова, Т.М. Остроумова, О.А. Солоха, Т.А. Янакаева

References

1. Piradov MA, Suponeva NA, Grishina DA. Polyneuropathies: algorithms for diagnosis and treatment. Moscow: Goryachaya Liniya-Telecom; 2019. 248 p. (In Russian).
2. Akhmedzhanova LT, Barinov AN, Strokov IA, Misyuryayeva EV, Belyakova TA, Podkovko YuA. Algorithms for diagnosis and treatment of chronic autonomic neuropathies. Nervous Diseases 2019;3:31-6 (In Russian).
3. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003 Jun;26(6):1895-901.
4. Ricci F, Fedorowski A, Radico F, Romanello M, Tatasciore A, Di Nicola M, Zimarino M, De Caterina R. Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies. European Heart Journal 2015 Jul;36(25):1609-17.
5. Rose KM, Eigenbrodt ML, Biga RL, Couper DJ, Light KC, Sharrett AR, Heiss G. Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 2006 Aug;114(7):630-6.
6. Israel CW, Lee-Barkey YH. Sudden cardiac death in diabetes mellitus. Herz 2016 May;41(3):193-200.
7. Shams A, Morley JE. Autonomic neuropathy and cardiovascular disease in aging. The Journal of Nutrition, Health and Aging 2018;22(9):1028-33.
8. Kempler P. Neuropathies: pathomechanism, clinical presentation, diagnosis, therapy. Budapest: Springer Scientific Publishers; 2002. 208 p.
9. Agashe S, Petak S. Cardiac autonomic neuropathy in diabetes mellitus. Methodist DeBakey Cardiovascular Journal 2018 Oct-Dec;14(4):251-6.
10. Merkulov YuA, Kalashnikov AA, Pyatkov AA, Shcherbenkova AL, Chernova PA, Merkulova DM. Cardiovascular manifestations of vegetative polyneuropathy. SS Korsakov Journal of Neurology and Psychiatry 2011;111(9):77-9 (In Russian).
11. Nesti L, Pugliese NR, Sciuto P, Natali A. Type 2 diabetes and reduced exercise tolerance: a review of the literature through an integrated physiology approach. Cardiovascular Diabetology 2020;19(1):134.
12. Ostroumova OD, Chernyaeva MS, Petrova MM, Golovina OV. Orthostatic hypotension: definition, pathophysiology, classification, prognostic aspects, diagnosis and treatment. Rational Pharmacotherapy in Cardiology 2018;14(5):747-56 (In Russian).
13. Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, Karabin B, Kuritzky L, Lew M, Low P, Mehdirad A, Raj SR, Vernino S, Kaufmann H. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. Journal of Neurology 2017 Aug;264(8):1567-82.
14. Nguyen L, Wilson LA, Miriel L, Pasricha PJ, Kuo B, Hasler WL, McCallum RW, Sarosiek I, Koch KL, Snape WJ, Farrugia G, Grover M, Clarke J, Parkman HP, Tonascia J, Hamilton F, Abell TL; NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Autonomic function in gastroparesis and chronic unexplained nausea and vomiting: relationship with etiology, gastric emptying, and symptom severity. Neurogastroenterology and Motility 2020 Aug;32(8):e13810.
15. Marathe CS, Jones KL, Wu T, Rayner CK, Horowitz M. Gastrointestinal autonomic neuropathy in diabetes. Autonomic Neuroscience 2020 Dec;229:102718.
16. Braffett BH, Wessells H, Sarma AV. Urogenital autonomic dysfunction in diabetes. Current Diabetes Reports 2016 Dec;16(12):119.
17. Tatarchenko IP, Zaytseva AV, Molokova EA. Silent myocardial ischemia as a result of autonomic cardiac neuropathy. Kardiologiia 2019;59(5):13-7 (In Russian).
18. Agashe S, Petak S. Cardiac autonomic neuropathy in diabetes mellitus. Methodist DeBakey Cardiovascular Journal 2018 Oct-Dec;14(4):251-6.
19. Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH; EURODIAB Prospective Complications Study Group. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care 2008 Jul;31(7):1360.
20. Forsén A, Kangro M, Sterner G, Norrgren K, Thorsson O, Wollmer P, Sundkvist G. A 14-year prospective study of autonomic nerve function in type 1 diabetic patients: association with nephropathy. Diabetic Medicine 2004 Aug;21(8):852-8.
21. Cohen JA, Estacio RO, Lundgren RA, Esler AL, Schrier RW. Diabetic autonomic neuropathy is associated with an increased incidence of strokes. Autonomic Neuroscience 2003 Oct;108(1-2):73-8.
22. Gibbons CH, Freeman R. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain 2015 Jan;138(Pt 1):43-52.
23. Julian TH, Syeed R, Glascow N, Zis P. Alcohol-induced autonomic dysfunction: a systematic review. Clinical Autonomic Research 2020 Feb;30(1):29-41.
24. Angelcheva OI, Zinovyeva OE, Yakhno NN. Neuromuscular disorders in chronic alcoholism. Moscow: MEDpress-inform; 2009. 70 p. (In Russian).
25. Safiulina EI, Zinovyeva OE, Rameyev VV, Kozlovskaya-Lysenko LV. Peripheral nervous system involvement in systemic amyloidosis. Neurology, Neuropsychiatry, Psychosomatics 2018;10(3):12-8 (In Russian).
26. Kaur D, Tiwana H, Stino A, Sandroni P. Autonomic neuropathies. Muscle & Nerve 2021 Jan;63(1):10-21.
27. Treister R, O’Neil K, Downs HM, Oaklander AL. Validation of the composite autonomic symptom scale 31 (COMPASS-31) in patients with and without small fiber polyneuropathy. European Journal of Neurology 2015 Jul;22(7):1124-30.
28. Barinov AN. Vegetative neuropathy in diabetes mellitus and metabolic syndrome: clinical manifestations, diagnosis and treatment. Effective Pharmacotherapy 2017;29:40-50 (In Russian).
29. McAnany JJ, Smith BM, Garland A, Kagen SL. iPhone-based pupillometry: a novel approach for assessing the pupillary light reflex. Optometry and Vision Science 2018;95(10):953-8.
30. Bhati P, Alam R, Moiz JA, Hussain ME. Subclinical inflammation and endothelial dysfunction are linked to cardiac autonomic neuropathy in type 2 diabetes. Journal of Diabetes & Metabolic Disorders 2019 Aug;18(2):419-28.
31. Ziegler D, Hanefeld M, Ruhnau KJ, Meissner HP, Lobisch M, Schütte K, Gries FA. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxydant alpha-lypoic acid. A 3-week multicentre randomized controlled trial. (ALADIN study group). Diabetologia 1995 Dec;38(12):1425-33.
32. Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, Low PA, Nehrdich D, Novosadova M, O’Brien PC, Reljanovic M, Samigullin R, Schuette K, Strokov I, Tritschler HJ, Wessel K, Yakhno N, Ziegler D; SYDNEY Trial Study Group. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 2003 Mar;26(3):770-6.
33. Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schütte K, Kerum G, Malessaand R. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999 Aug;22(8):1296-301.
34. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006 Nov;29(11):2365-70.
35. Gomes MB, Negrato CA. Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases. Diabetology & Metabolic Syndrome 2014 Jul;6(1):80.
36. Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, Reichel G. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care 1997 Mar;20(3):369-73.
37. Tankova T, Koev D, Dakovska L. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study). Romanian Journal of Internal Medicine 2004;42(2):457-64.
38. Yemelyanova AYu, Zinovyeva OE. Alcoholic polyneuropathy: clinical and pathogenetic variants, principles of diagnosis and treatment. Effective Pharmacotherapy 2015;13:28-36 (In Russian).
  

[ Содержание выпуска N 4 | Выпуски журнала | Список журналов ]